Welcome to LookChem.com Sign In|Join Free

CAS

  • or

97337-30-9

Post Buying Request

97337-30-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97337-30-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97337-30-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,3,3 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 97337-30:
(7*9)+(6*7)+(5*3)+(4*3)+(3*7)+(2*3)+(1*0)=159
159 % 10 = 9
So 97337-30-9 is a valid CAS Registry Number.

97337-30-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-hydroxy-2-sulfanylidene-1,7-dihydropyrrolo[2,3-d]pyrimidin-4-one

1.2 Other means of identification

Product number -
Other names 4,6(3H,5H)-dioxopyrrolo<2,3-d>pyrimidine-2(1H)-thione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:97337-30-9 SDS

97337-30-9Relevant articles and documents

Synthesis and Biological Activity of Certain 6-Substituted and 2,6-Disubstituted 2'-Deoxyturbercidins Prepared via the Stereospecific Sodium Salt Glycosylation Procedure

Cottam, Howard B.,Kazimierczuk, Zygmunt,Geary, Stewart,McKernan, Patricia A.,Revankar, Ganapathi R.,Robins, Roland K.

, p. 1461 - 1467 (2007/10/02)

A number of 6-substituted and 2,6-disubstituted pyrrolopyrimidine 2'-deoxyribonucleosides were prepared by the direct stereospecific sodium salt glycosylation procedure.Reaction of the sodium salt of 4-chloro-6-methyl-2-(methylthio)pyrrolopyrimidine (6a) or 4,6-dichloro-2-(methylthio)pyrrolopyrimidine (6b) with 1-chloro-2-deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofuranose (9) provided the corresponding N7 2'-deoxy-β-D-ribofuranosyl blocked derivatives (8a and 8c) which, on ammonolysis, gave 4-amino-6-methyl-2-(methylthio)-7-(2-deoxy-β-D-erythro-pentofuranosyl)pyrrolopyrimidine (11a) and 4-amino-6-chloro-2-(methylthio)-7-(2-deoxy-β-D-erythro-pentofuranosyl)pyrrolopyrimidine (11b), respectively.Dethiation of 11a and 11b afforded 6-methyl-2'-deoxytubercidin (10a) and 6-chloro-2'-deoxytubercidin (10b), respectively.Dehalogenation of 10b provided an alternate route to the reported 2'-deoxytubercidin (3a).Application of this glycosylation procedure to 4,6-dichloro and 4,6-dichloro-2-methyl derivatives of pyrrolopyrimidine (15a and 15b) gave the corresponding blocked 2'-deoxyribonucleosides (18a and 18b), which on ammonolysis furnished 10b and 4-amino-6-chloro-2-methyl-7-(2-deoxy-β-D-erythro-pentofuranosyl)pyrrolopyrimidine (17), respectively.This stereospecific attachment of the 2-deoxy-β-D-ribofuranosyl moiety appears to be due to a Walden inversion at the C1 carbon by the anionic heterocyclic nitrogen.Controlled deacylation of 4-chloro-7-(2-deoxy-3,5-di-O-p-toluoyl-β-D-erythro-pentofuranosyl)pyrrolopyrimidine (20a) gave 4-chloro-7-(2-deoxy-β-D-erythro-pentofuranosyl)pyrrolopyrimidine (20b).Dehalogenation of 20b gave the 2'-deoxynebularin analogue 7-(2-deoxy-β-D-erythro-pentofuranosyl)pyrrolopyrimidine (19), and reaction of 20b with thiourea gave 7-(2-deoxy-β-D-erythro-pentofuranosyl)pyrrolopyrimidine-4(3H)-thione (21).All of these compounds were tested in vitro against certain viruses and tumor cells.Only compounds 12a, 20b, and 21 showed significant activity against measles in vitro, and the activity is comparable to that of ribavirin.Although compounds 3a and 12b are slightly more active than ribavirin against HSV-2 in vitro, they are relatively more toxic to Vero cells.Compounds 3a and 20b exhibited moderate cytostatic ativity against L1210 and P388 leukemia in vitro but are considerably less active than 2-chloro-2'-deoxyadenosine (1).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 97337-30-9